Pure Global
NCT06347692

Effect of Antigravity Treadmill in Knee Osteoarthritis (AGTreadmill)

Effect of Antigravity Treadmill Training on Pain, Gait Characteristics, and Function in Patients With Knee Osteoarthritis- A Randomized Controlled Trial
Prince Sattam Bin Abdulaziz University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Knee Osteoarthritis
Drug/Device/Intervention
antigravity treadmill
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Prince Sattam Bin Abdulaziz University
Timeline & enrollment
Phase
N/A
Start date
Apr 07, 2024
End date
Apr 20, 2025
Enrollment
40 participants
Primary outcome

Assessment of patient pain,Evaluation of gait parameters (step length),Evaluation of gait parameters (step time),Evaluation of gait parameters (velocity),Evaluation of patient function

Summary

To date, the anti-gravity treadmill, as a representative method of lower body positive
 pressure treadmills, has been rarely reported for knee osteoarthritis rehabilitation.
 
 Purpose: This study aims to evaluate the effect of antigravity treadmill training on pain,
 gait characteristics, and function in patients with knee osteoarthritis.

ICD-10 classifications
Chronic instability of kneeGonarthrosis [arthrosis of knee]Other hypertrophic osteoarthropathyDislocation, sprain and strain of joints and ligaments of kneePatellofemoral disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06347692
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06347692 through Pure Global AI's free database. This phase not specified trial is sponsored by Prince Sattam Bin Abdulaziz University and is currently Not yet recruiting. The study focuses on Knee Osteoarthritis. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.